Back to Search
FARHAN SHEIKH, M.D.
M.D.
Anesthesiology Physician
NPI: 1801882774Individual
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
123272-1(NY)
Research & Publications (20)
Unexpected transesophageal echocardiogram finding during an aortic valve replacement.
PMID 11505362·J Cardiothorac Vasc Anesth·2001
5-case
Novel self-assembled amphiphilic poly(epsilon-caprolactone)-grafted-poly(vinyl alcohol) nanoparticles: hydrophobic and hydrophilic drugs carrier nanoparticles.
PMID 19020953·J Mater Sci Mater Med·2009
8-other
Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death.
PMID 19001090·Mol Cell Biol·2009
7-preclinical
Oncostatin M regulates secretoglobin 3A1 and 3A2 expression in a bidirectional manner.
PMID 18978304·Am J Respir Cell Mol Biol·2009
7-preclinical
Left ventricular myocardial injury and syncope due to pulmonary embolism in a soldier: normal coronaries and novel pathologic electrocardiogram signs.
PMID 18700608·Mil Med·2008
5-case
Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain.
PMID 18066066·Nat Immunol·2008
7-preclinical
An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice.
PMID 19033658·J Clin Invest·2008
7-preclinical
FGF-16 is required for embryonic heart development.
PMID 18565327·Biochem Biophys Res Commun·2008
7-preclinical
IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity.
PMID 18698163·Cancer Biol Ther·2008
7-preclinical
A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis.
PMID 17442890·Mol Biol Cell·2007
8-other
Transforming growth factor-beta as a differentiating factor for cultured smooth muscle cells.
PMID 17596270·Eur Respir J·2007
7-preclinical
Identification, evolution, and association study of a novel promoter and first exon of the human NOD2 (CARD15) gene.
PMID 17719742·Genomics·2007
7-preclinical
The Clinical Outcomes Utilizing Revascularizaton and Aggressive Drug Evaluation trial: a vindication of the power of medical therapy for the secondary prevention of coronary heart disease.
PMID 18082532·Am J Cardiol·2007
8-other
Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling.
PMID 17093501·Genes Immun·2007
7-preclinical
"Z"eroing in on the role of Cypher in striated muscle function, signaling, and human disease.
PMID 18021935·Trends Cardiovasc Med·2007
6-review
Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.
PMID 16618774·Cancer Res·2006
7-preclinical
CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates.
PMID 16700710·Clin Microbiol Infect·2006
4-observational
DRB3.2 gene polymorphism and its association with pashmina production in Changthangi goat.
PMID 16893391·Int J Immunogenet·2006
7-preclinical
alpha-E-catenin inactivation disrupts the cardiomyocyte adherens junction, resulting in cardiomyopathy and susceptibility to wall rupture.
PMID 16923756·Circulation·2006
7-preclinical
Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.
PMID 16982608·J Biol Chem·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 47 NEW SCOTLAND AVE
ALBANY, NY 12208 - Phone
- (518) 262-4300
Quick Facts
- NPI
- 1801882774
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile